Generate a tailored SOP for Dr. Kevin Selva. Improve your application with a focused, well-structured draft.
Kevin John Selva is an Early Career Researcher who focuses on protective mucosal immunity against infectious diseases. After completing his PhD in 2019, he joined the Chung group at the Doherty Institute, where he leads research on mucosal antibodies against respiratory infectious diseases, including tuberculosis, SARS-CoV-2, and influenza, across different age groups such as children, adults, and the elderly. His work on COVID-19 has demonstrated that children have superior immune responses against SARS-CoV-2 compared to older adults, a finding that is attributed to biases in pre-existing immunity. Kevin has authored numerous publications in prestigious journals like Nature Communications and Cell Reports Medicine, contributing to over 20 publications, several of which have informed government policies. His research is recognized through various awards, including the ASI Career Advancement Award and the University of Melbourne Early Career Researcher Grant, which have supported his work in mucosal antibody research.